BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 9748148)

  • 1. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
    Frank DK; Liu TJ; Frederick MJ; Clayman GL
    Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
    Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
    Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines.
    Liu TJ; Wang M; Breau RL; Henderson Y; El-Naggar AK; Steck KD; Sicard MW; Clayman GL
    Cancer Gene Ther; 1999; 6(2):163-71. PubMed ID: 10195883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
    Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines.
    Zhang SY; Liu SC; Johnson DG; Klein-Szanto AJ
    Cancer Res; 2000 Nov; 60(21):5972-6. PubMed ID: 11085515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.
    Divan A; Lawry J; Dunsmore IR; Parsons MA; Royds JA
    Cancer Res; 2001 Apr; 61(7):3157-63. PubMed ID: 11306502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53.
    Hunt KK; Deng J; Liu TJ; Wilson-Heiner M; Swisher SG; Clayman G; Hung MC
    Cancer Res; 1997 Nov; 57(21):4722-6. PubMed ID: 9354430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras modulates the cell cycle via both positive and negative regulatory pathways.
    Fan J; Bertino JR
    Oncogene; 1997 May; 14(21):2595-607. PubMed ID: 9191059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
    Chen Q; Hung FC; Fromm L; Overbeek PA
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of p21waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells.
    Li WW; Fan J; Hochhauser D; Bertino JR
    Cancer Res; 1997 Jun; 57(11):2193-9. PubMed ID: 9187120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
    Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
    Ramondetta L; Mills GB; Burke TW; Wolf JK
    Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.
    Draus JM; Elliott MJ; Atienza C; Stilwell A; Wong SL; Dong Y; Yang H; McMasters KM
    Exp Mol Med; 2001 Dec; 33(4):209-19. PubMed ID: 11795482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
    Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
    Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines.
    Li JH; Li P; Klamut H; Liu FF
    Clin Cancer Res; 1997 Apr; 3(4):507-14. PubMed ID: 9815713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
    Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL
    Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.